Skip to content

Clinical trials

Completed Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Clear all

273 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20022
20035
20046
200517
200613
200713
200813
200915
201023
201125
201215
201310
201417
201512
201611
201712
201812
20196
20209
20219
20227
20234
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed273

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
National Cancer Institute (NCI)8
M.D. Anderson Cancer Center7
Memorial Sloan Kettering Cancer Center7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins7
Eli Lilly and Company6
H. Lee Moffitt Cancer Center and Research Institute6
Stanford University4
UNICANCER4
University Health Network, Toronto4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma273
Neoplasms63
Pancreatic Neoplasms47
Carcinoma, Non-Small-Cell Lung42
Neoplasm Metastasis36
Lung Neoplasms32
Carcinoma30
Carcinoma, Squamous Cell26
Prostatic Neoplasms25
Stomach Neoplasms23

Trials

Showing 76 to 100 of 273. Each trial links to its page on Pharma Observatory.

173 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.